振东制药：12月18日召开董事会会议

Group 1 - The core point of the article is that Zhendong Pharmaceutical held its 10th meeting of the 6th Board of Directors on December 18, 2025, to discuss the election of members for the Compensation and Assessment Committee [1] - For the first half of 2025, Zhendong Pharmaceutical's revenue composition includes: 110.27% from pharmaceutical production and sales, 31.67% from medicinal herb planting, 3.38% from technical services, and -45.32% from inter-segment eliminations [1] - As of the report date, Zhendong Pharmaceutical has a market capitalization of 6 billion yuan [1]